Picture of Amedisys logo

AMED Amedisys Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Annual cashflow statement for Amedisys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line128185210118-10.9
Depreciation
Deferred Taxes
Non-Cash Items73.675.334.372.3167
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-31.426.2-131-105-63.2
Change in Accounts Receivable
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities202289189133137
Capital Expenditures-7.89-5.33-6.72-7.21-12.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-345-282-275-87.347.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-353-287-282-94.535.1
Financing Cash Flow Items-11.54.38-81.2-5.94-14.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities227-1555.1-30.4-87.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash76.3-13.1-37.68.3684.7